Advertisement
New Zealand markets closed
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NZD/USD

    0.5973
    -0.0002 (-0.04%)
     
  • NZD/EUR

    0.5540
    +0.0007 (+0.13%)
     
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • ASX 200

    7,896.90
    +77.30 (+0.99%)
     
  • OIL

    83.11
    -0.06 (-0.07%)
     
  • GOLD

    2,254.80
    +16.40 (+0.73%)
     
  • NASDAQ

    18,254.69
    -26.15 (-0.14%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • Dow Jones

    39,807.37
    +47.29 (+0.12%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • NIKKEI 225

    40,369.44
    +201.37 (+0.50%)
     
  • NZD/JPY

    90.3710
    -0.0220 (-0.02%)
     

Correction: Form 8.3 - Horizon Therapeutics plc

                        FORM 8.3

 

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

State Street Global Advisors & Affiliates

Company dealt in

Horizon Therapeutics plc

Class of relevant security to which
the dealings being disclosed relate (Note 2)

$0.0001 ordinary shares

Date of dealing

30th Nov 2022

 

 

 

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

ADVERTISEMENT

 

 

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

5,974,957

2.63582%

 

 

(2) Derivatives (other than options)

508

0.000224%

 

 

(3) Options and agreements to
purchase/sell

N/A

N/A

 

 

Total

5,975,465

2.63605%

 

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 

Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

N/A

 

 

 

(2) Derivatives (other than options)

N/A

 

 

 

(3) Options and agreements to purchase/sell

N/A

 

 

 

Total

N/A

 

 

 

 

 

3. DEALINGS (Note 4)

 

(a) Purchases and sales

 

Purchase/sale

Number of relevant securities

Price per unit (Note 5)

Purchase

600

100.29

Purchase

300

100.29

Purchase

111

100.29

Purchase

100

100.29

Purchase

9,000

100.29

Purchase

1,500

100.29

Purchase

200

99.99

Purchase

400

100.29

Purchase

700

100.29

Purchase

64,980

100.29

Purchase

6,300

100.29

Purchase

400

100.29

Purchase

800

100.29

Purchase

167

100.29

Purchase

596

100.29

Purchase

300

100.29

Purchase

1,600

100.29

Purchase

3,200

100.29

Purchase

300

100.29

Purchase

1,600

100.29

Purchase

34

100.29

Purchase

100

100.29

Sale

400

100.29

Sale

800

100.29

Sale

2,052

100.29

Sale

300

100.29

Sale

700

100.29

Sale

1,500

100.29

Sale

400

100.29

Sale

400

100.29

Sale

1,100

100.29


 

(b) Derivatives transactions (other than options transactions)

 

Product name,
e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

N/A

 

 

 

 

        

(c) Options transactions in respect of existing relevant securities

 

(i) Writing, selling, purchasing or varying

 

Product name,
e.g. call option

Writing, selling,
purchasing
varying etc.

Number of
securities to which
the option relates
(Note 7)

Exercise
price

Type, e.g.
American,
European etc.

Expiry
date

Option money
paid/received
per unit (Note 5)

N/A

 

 

 

 

 

 

 

 

(ii) Exercising

 

Product name,
e.g. call option

Number of securities

Exercise price per
unit (Note 5)

N/A

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction
(Note 8)

Details

Price per unit
(if applicable) (Note 5)

N/A

 

 

 

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

N/A

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)

NO

Date of disclosure

1st Dec 2022

Contact name

Lionel Colaco

Telephone number                                

020 33956098

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A